Skip to content
Search

Latest Stories

Dr Reddy's enters UK consumer health market, launches allergy medication Histallay

Dr Reddy's enters UK consumer health market, launches allergy medication Histallay

People with hay fever can now get direct access to the product through pharmacies and supermarkets in the UK.  

Indian multinational pharmaceutical company, Dr. Reddy's Laboratories has made its entry into the UK consumer health market with the launch of an over-the-counter allergy medication.


Histallay (Fexofenadine Hydrochloride 120 mg tablets) is the company’s first general sale list (GSL) product introduced in the UK market.

Previously classified as a Prescription Only Medicine (POM), Dr. Reddy's Fexofenadine 120 mg is now available without prescription, under the brand name ‘Histallay’.

This allows people with allergic seasonal rhinitis (hay fever) to get direct access to the product via retail outlets such as pharmacies and supermarkets in the UK.

The Indian company said it is already one of the largest producers of Fexofenadine Hydrochloride ( the active pharmaceutical ingredient in Histallay), which is the most dispensed antihistamine in the UK.

“Entering consumer healthcare is a logical step for us and true to our purpose of offering more choices for customers and patients.

“Our expertise in the allergy segment has already allowed us to become a leader in the UK’s prescription fexofenadine market.

“By making Histallay available over the counter, we enable allergy sufferers to get faster access to treatment and better control over their symptoms since early treatment is key,” the company writes on its website.

Screenshot 2024 01 25 164551

What is Hay fever?

Hay fever, also called allergic rhinitis, is an allergic reaction commonly triggered by pollen, house dust mites, mould spores, and pet dander.

According to NHS, cases are higher between late March and September, when the pollen count is at its highest.

Hay fever causes cold-like symptoms, including a runny or blocked nose, sneezing and coughing, itchy eyes and throat, loss of smell, headache, earache, and tiredness.

For people with asthma, their symptoms may get worse when they have hay fever. They may experience a tight feeling in the chest, shortness of breath, wheezing, and cough.

While a cold usually goes away after 1 to 2 weeks, hay fever can last for weeks or months, the health service stated.

How to treat hay fever

Unfortunately, there's currently no cure for hay fever, but treatment can help relieve symptoms at least to a certain extent for most people.

Hay fever treatments include antihistamines (for preventing an allergic reaction) and corticosteroids or steroids (for reducing inflammation and swelling).

If you have hay fever, you can speak to your pharmacist, who can give you advice and suggest the best treatments.

The NHS advised people to see a doctor if their symptoms do not improve after taking medicines from the pharmacy and are getting worse.

More For You

Vaccine-preventable infections costing UK billions

Effective interventions are needed to prevent hospitalisations

Vaccine-preventable infections costing UK billions

Effective interventions are having a positive impact but more needs to be done to combat vaccine-preventable infections after data revealed today showed that it accounted for 20 per cent of hospital bed usage in the UK between 2023 to 2024 at a cost of almost £6 billion.

The return of social mixing, international travel and migration following the COVID-19 pandemic have contributed to the rise in both endemic disease and vaccine-preventable infections, according to the UK Health Security Agency's (UKHSA).

Keep ReadingShow less
Economic analysis of pharmacy finances will be published ‘imminently’ - Stephen Kinnock

Stephen Kinnock also confirms that the outcome of the negotiations with CPE will be announced "very soon."

parliamentlive.tv

NPA collective action “premature, unnecessary and detrimental to patients” - Stephen Kinnock

Health Minister Stephen Kinnock has announced that the government will be releasing the independent economic analysis of pharmacy finances “imminently.”

Responding to a question from shadow health minister Dr. Luke Evans in Parliament today (25), Kinnock criticised the National Pharmacy Association’s (NPA) collective action as “premature, unnecessary, and detrimental to community pharmacy patients.”

Keep ReadingShow less
NPA members are expected reduce opening hours and services from next week

NPA members are expected reduce opening hours and services from next week

Pic credit: iStock

NPA will become more “militant” as wait for pharmacy contract goes on

The government has been warned by the National Pharmacy Association (NPA) that community pharmacy will not back down from collective action and reducing opening hours from April 1st.

NPA board member, Ashley Cohen, told LBC today that the sector was in a "desperate situation" and that the representative body will do “whatever we can to protect our sector”.

Keep ReadingShow less
Community pharmacy needs investment and support to deliver neighbourhood health, says CCA chief

Community pharmacies see patients more than anyone else in the primary care system.

Getty Images

Community pharmacy key to neighbourhood health, but investment needed, says CCA chief

Community pharmacies can play a vital role in delivering a ‘neighbourhood health service’, provided they receive the necessary investment and support, according to Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA).

Harrison's comments come in response to a new report from think tank Reform, titled Designing a Neighbourhood Health Service, which outlines key principles for achieving the government's vision of a more community-focused healthcare system.

Keep ReadingShow less
Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less